SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: travisnye who wrote (11889)4/17/2013 12:08:18 PM
From: Mimbari3 Recommendations  Read Replies (1) | Respond to of 13111
 
This stock doesn't trade in a volume high enough to put reliability into graphs. It also is a company with no income yet. So graphing the trends is mute. This is a stock, however, that goes up and down plus and minus 50cents until either big pharm's make big deals or it is bought out. SPA's and phase III's are just news and not income. Getting onto NASDQ will allow life science investors to jump in and that would raise the price. So the time line will be this: regional deal with China most likely, then a price bump, NASDQ, life science investments, global deal along with ending phase III early. This stock will stay low until big news. Now applying for BTD and receiving a positive reply will cause this all to happen in less that six months instead of another year and a half, a snowball already rolling down hill.



To: travisnye who wrote (11889)4/18/2013 12:08:00 PM
From: dirkdiggler2 Recommendations  Read Replies (1) | Respond to of 13111
 
The problem with the stock price is dilution of share price every time they make a new offering for capital your ownership is diluted. Last time they made the preferred share disaster, the price dropped like a rock. They will need to raise a considerable amount of capital for a phase 3; and, phase 3 studies are the most expensive and could run about 4 times as high as a phase 2.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News